Research Papers:

Ceramide species are elevated in human breast cancer and are associated with less aggressiveness

Kazuki Moro, Tsutomu Kawaguchi, Junko Tsuchida, Emmanuel Gabriel, Qianya Qi, Li Yan, Toshifumi Wakai, Kazuaki Takabe and Masayuki Nagahashi _

PDF  |  HTML  |  How to cite

Oncotarget. 2018; 9:19874-19890. https://doi.org/10.18632/oncotarget.24903

Metrics: PDF 2015 views  |   HTML 4263 views  |   ?  


Kazuki Moro1, Tsutomu Kawaguchi2, Junko Tsuchida1, Emmanuel Gabriel2, Qianya Qi3, Li Yan3, Toshifumi Wakai1, Kazuaki Takabe1,2,4,5,6 and Masayuki Nagahashi1

1Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata City 951-8510, Japan

2Breast Surgery, Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, USA

3Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, USA

4Department of Surgery, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, The State University of New York, Buffalo, New York 14203, USA

5Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo 160-8402, Japan

6Department of Surgery, Yokohama City University, Yokohama 236-0004, Japan

Correspondence to:

Masayuki Nagahashi, email: [email protected]

Kazuaki Takabe, email: [email protected]

Keywords: breast cancer; ceramide; metabolism; prognosis; sphingolipid

Received: October 07, 2017    Accepted: March 12, 2018    Published: April 13, 2018


Sphingolipids have emerged as key regulatory molecules in cancer cell survival and death. Although important roles of sphingolipids in breast cancer progression have been reported in experimental models, their roles in human patients are yet to be revealed. The aim of this study was to investigate the ceramide levels and its biosynthesis pathways in human breast cancer patients. Breast cancer, peri-tumor and normal breast tissue samples were collected from surgical specimens from a series of 44 patients with breast cancer. The amount of sphingolipid metabolites in the tissue were determined by mass spectrometry. The Cancer Genome Atlas was used to analyze gene expression related to the sphingolipid metabolism. Ceramide levels were higher in breast cancer tissue compared to both normal and peri-tumor breast tissue. Substrates and enzymes that generate ceramide were significantly increased in all three ceramide biosynthesis pathways in cancer. Further, higher levels of ceramide in breast cancer were associated with less aggressive cancer biology presented by Ki-67 index and nuclear grade of the cancer. Interestingly, patients with higher gene expressions of enzymes in the three major ceramide synthesis pathways showed significantly worse prognosis. This is the first study to reveal the clinical relevance of ceramide metabolism in breast cancer patients. We demonstrated that ceramide levels in breast cancer tissue were significantly higher than those in normal tissue, with activation of the three ceramide biosynthesis pathways. We also identified that ceramide levels have a significant association with aggressive phenotype and its enzymes have prognostic impact on breast cancer patients.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24903